Zhengchuan Co., Ltd. (603976.SH): The company is actively expanding the market for high-end products such as pre-filled syringe assemblies, cartridges, and disposable injector bottles. Currently, it is still in the market development stage

Gelonghui, May 8, 丨 Zhenchuan Co., Ltd. (603976.SH) Investor Relations Activity Record Sheet shows that the company is actively expanding the market for high-end products such as pre-filled syringe assemblies, cartridges, and disposable injection bottles, and is currently still in the market development stage. According to market demand and the actual situation of market development, production capacity will be gradually released, and efforts will be made to form new profit growth points through new products.

Gelonghui FinanceMay 8 03:51 ET

Zhengchuan Co., Ltd. (603976.SH): The current trend of medium boron replacing low shelf products is still quite obvious

Gelonghui, May 8 | Zhengchuan Co., Ltd. (603976.SH) Investor Relations Activity Record Sheet shows that the current trend of boron replacing low-shelf products with medium boron is still quite obvious, and the share of boron in individual markets is gradually increasing. There is a clear trend of localization in the borosilicate control bottle market. With the improvement in the quality of domestic control bottles and the price advantage compared to imported ones, the localization rate of borosilicate control bottles is expected to increase further.

Gelonghui FinanceMay 8 03:51 ET

Zhengchuan Co., Ltd. (603976.SH): Net profit decreased by 37.83% in 2023 to 40.267,700 yuan, and plans to pay 2 yuan

On April 26, Ge Longhui Co., Ltd. (603976.SH) released its 2023 annual report, achieving operating income of 901 million yuan, an increase of 13.12%; net profit attributable to shareholders of listed companies of 40.267,700 yuan, a year-on-year decrease of 37.83%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 298.623 million yuan, a year-on-year decrease of 48.23%; and basic earnings per share of 0.27 yuan. It is proposed to distribute a cash dividend of 2 yuan (tax included) for every 10 shares to all shareholders.

Gelonghui FinanceApr 26 11:13 ET

Zhengchuan Co., Ltd. (603976.SH): Net profit of 21.4476 million yuan in the first quarter increased 61.97% year-on-year

On April 26, Ge Longhui Co., Ltd. (603976.SH) released its report for the first quarter of 2024, achieving operating income of 246 million yuan, an increase of 8.94%; net profit attributable to shareholders of listed companies of 20.0476 million yuan, an increase of 61.97% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 20.3823 million yuan, an increase of 88.37% year on year; basic earnings per share of 0.14 yuan.

Gelonghui FinanceApr 26 11:03 ET

ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd's (SHSE:603976) Stock Price Dropped 18% Last Week; Private Companies Would Not Be Happy

Key Insights Significant control over ChongQing Zhengchuan Pharmaceutical PackagingLtd by private companies implies that the general public has more power to influence management and governance-relate

Simply Wall StApr 16 20:16 ET

[BT Financial Report Instantaneous Analysis] Zhengchuan Co., Ltd. 2023 Q3 Report: Net profit declined, net cash flow increased sharply

This financial report was announced on 2023-10-25 16:20:02. Zhengchuan Co., Ltd. (stock code: 603976) is an enterprise focusing on the pharmaceutical packaging materials industry, mainly engaged in R&D, production and sales of pharmaceutical packaging materials such as pharmaceutical glass control bottles. The company has more than 30 years of development experience in the field of pharmaceutical glass and is one of the leading enterprises in the domestic pharmaceutical glass control bottle segment. According to the company's 2023 three-quarter report, the company's total assets were 2,081 billion yuan, up 3.64% from 2,008 billion yuan at the end of the previous year. Total liabilities were $870 million, compared to

businesstimes cnOct 31, 2023 03:12 ET